Tax Exclusion For Health Benefits Could Be Part Of 'Fiscal Cliff' Talks

Published Online: December 14, 2012
As the deficit debate continues, some policy wonks think it’s inevitable that negotiators will address a loophole that allows workers to avoid paying taxes on the value of their job-based health insurance.

“The No. 1 tax expenditure is employer-provided health insurance,” said G. William Hoagland, a senior vice president at the Bipartisan Policy Center, who spoke Thursday at a conference sponsored by the Employee Benefit Research Institute. “There’s no way on God’s green earth … that we will not see that exclusion on the table.”

Read the full story: http://bit.ly/lzzeJp

Source: Kaiser Health News

Feature
Recommended Articles
Officials say the number of enrollees and their relative good health made it possible to negotiate lower rate increases. However, premium increases are higher in Northern California, where there is less competition.
Commercial health plans will soon face a new Federal rule that will require them to provide counseling to obese and some overweight beneficiaries—and most will need help complying. Omada Health co-founder and CEO Sean Duffy, writing this month in Evidence-Based Diabetes Management, tells how the CDC has opened the door for digital health programs to offer a scalable, effective solution.
Before “value” became a cancer care buzzword, The American Journal of Managed Care was the first to create a conference where stakeholders discussed how to deliver the best care possible—and figure out how to pay for it. The fourth installment of Patient-Centered Oncology Care on November 19-20, 2015, in Baltimore, Maryland, will address the regulation of molecular diagnostics and ongoing efforts at payment reform.
What are managed care readers following so far in 2015? At the midway point of celebrating its 20th year of publication, The American Journal of Managed Care lists the most-read articles from its print journals over the first 6 months.
Recent surveys have found that public sentiment on drug costs runs high and crosses the political divide. A move this week by the nation's leading oncologists to rein in therapy pricing may be a sign that this is the breakthrough issue of the presidential campaign.